In this week’s Sg2 Perspectives, host Jayme Zage, PhD, is joined by Sg2 Associate Principal Justin Cassidy, PhD, to discuss what’s going on in the cell and gene therapy space. Justin talks about the increasing approvals of gene therapies and their primary barriers and challenges, as well as who should be involved in the decisions about receiving these therapies and how providers and manufacturers can gain patients’ trust. 
 
We are always excited to get ideas and feedback from our listeners. You can reach us at [email protected], or visit the Sg2 company page on LinkedIn.

Ver todos los episodios